scispace - formally typeset
S

Subramania Iyer

Researcher at Amrita Institute of Medical Sciences and Research Centre

Publications -  158
Citations -  1965

Subramania Iyer is an academic researcher from Amrita Institute of Medical Sciences and Research Centre. The author has contributed to research in topics: Medicine & Cancer. The author has an hindex of 19, co-authored 135 publications receiving 1503 citations. Previous affiliations of Subramania Iyer include Amrita Vishwa Vidyapeetham.

Papers
More filters
Journal ArticleDOI

Challenges to effective cancer control in China, India, and Russia

TL;DR: The overall state of health and cancer control in each country is described and additional specific issues for consideration are described: for China, access to care, contamination of the environment, and cancer fatalism and traditional medicine; for India, affordability of care, provision of adequate health personnel, and sociocultural barriers to cancer control.
Journal Article

Role of human papilloma virus in oral tongue squamous cell carcinoma.

TL;DR: A positive correlation of HPV infection with oral tongue cancer is confirmed and the expression of oncogenic proteins with targets is correlated with targets.
Journal ArticleDOI

Mouth self-examination to improve oral cancer awareness and early detection in a high-risk population

TL;DR: Overall awareness of oral cancer and its risk factors after introduction of MSE program was over 80%; but the compliance to seek treatment was poor, and Mouth self-examination may be used as an effective tool to improve the awareness of Oral cancer and for the early detection of lesions.
Journal ArticleDOI

Reconstructive indications of simultaneous double free flaps in the head and neck: A case series and literature review

TL;DR: Simultaneous use of double free flap aided the reconstruction in certain large complex defects after head and neck oncologic resections, and permits better complex multiaxial subunit reconstruction.
Journal ArticleDOI

Comparison of acute toxicities of two chemotherapy schedules for head and neck cancers.

TL;DR: Three weekly CT is less toxic than weekly, and can be made more acceptable by reducing the dose and using feeding tubes for nutrition.